The aging immune system and its relationship to the development of chronic obstructive pulmonary disease.
about
Age impacts pulmonary inflammation and systemic bone response to inhaled orgnic dust exposureSirtuin 1 and aging theory for chronic obstructive pulmonary diseaseThe aging lungTemporal trends in hospitalization rates for older adults with chronic obstructive pulmonary diseaseSuppressed expression of T-box transcription factors is involved in senescence in chronic obstructive pulmonary disease.Aging adversely affects the cigarette smoke-induced glutathione adaptive response in the lung.Delay of airway epithelial wound repair in COPD is associated with airflow obstruction severityRisk of herpes zoster among patients with chronic obstructive pulmonary disease: a population-based study.Lymphocyte senescence in COPD is associated with loss of glucocorticoid receptor expression by pro-inflammatory/cytotoxic lymphocytes.Asthma in the Elderly: Can We Distinguish It from COPD?T-cell biology in aging, with a focus on lung disease.Geroprotectors as a novel therapeutic strategy for COPD, an accelerating aging disease.Role of IL-6 in asthma and other inflammatory pulmonary diseases.Age-related increases in ozone-induced injury and altered pulmonary mechanics in mice with progressive lung inflammationDifferential Regulation of the Extracellular Cysteine/Cystine Redox State (EhCySS) by Lung Fibroblasts from Young and Old Mice.Inflammaging increases susceptibility to cigarette smoke-induced COPD.CYP2E1-dependent and leptin-mediated hepatic CD57 expression on CD8+ T cells aid progression of environment-linked nonalcoholic steatohepatitis.Spirometry use among older adults with chronic obstructive pulmonary disease: 1999-2008.Temporal complexity in clinical manifestations of lung disease.CD8+ CD28- and CD8+ CD57+ T cells and their role in health and disease.Mitochondrial dysfunction and oxidative stress activate inflammasomes: impact on the aging process and age-related diseases.Risk-to-benefit ratio of inhaled corticosteroids in patients with COPD.Managing older patients with coexistent asthma and chronic obstructive pulmonary disease: diagnostic and therapeutic challenges.Insight into older peoples' healthcare experiences with managing COPD, asthma, and asthma-COPD overlap.Maintaining lung health with longstanding HIV.A synopsis on aging-Theories, mechanisms and future prospects.β2-Microglobulin participates in development of lung emphysema by inducing lung epithelial cell senescence.Accuracy of forced oscillation technique to assess lung function in geriatric COPD population.Immunomodulatory effects of two different physical therapy modalities in patients with chronic obstructive pulmonary disease.Fructo-oligosaccharide attenuates the production of pro-inflammatory cytokines and the activation of JNK/Jun pathway in the lungs of D-galactose-treated Balb/cJ mice.Tumor microenvironment composition in pediatric classical Hodgkin lymphoma is modulated by age and Epstein-Barr virus infection.Association between TLR2/TLR4 gene polymorphisms and COPD phenotype in a Greek cohort.Role of increased CD8/CD28(null) T cells and alternative co-stimulatory molecules in chronic obstructive pulmonary disease
P2860
Q23914900-8C1CF1A7-391B-4342-B7C1-6CC0A57D8357Q26799889-7F6C7200-EE1E-4D7F-9909-2D409E14C903Q26823383-64EB5988-F309-4E89-BBDC-7E7B31AA75C2Q28391590-A0B90EB1-FD38-4190-8C58-A36286E04BE4Q34350843-21770607-1B0E-46B7-A0D4-672672EF935AQ34402384-A2014903-C488-4D80-8DE4-05C293D7CB52Q34611437-C0B6D983-9B18-40B7-A441-EDFB158596AFQ34693477-1FF677E9-F3C4-4ACE-8302-301ED25D8FF2Q34995450-56717F88-D336-4BFE-BA4F-1405B924A71EQ35110244-6DF9392E-796F-4CF3-BEC5-3F2F0FD90E44Q35815756-084E046F-CE2F-4A16-8DF6-C3EAD10EE699Q36283905-AA7A7897-93FD-4F36-9CF6-091C313B53CDQ36378245-6A45CFFE-4B2D-4BB1-86EE-8F8B6FFE05A3Q37234908-7CE61633-B988-478D-B855-52ED6FA17177Q37239707-151E51DF-E7DB-497F-BA45-DF4D76AC9699Q37327421-E21D5B5F-B391-488B-AEDD-8369E9947977Q37417528-9FB7B393-AAE7-46A7-9335-AA00694C0272Q37651702-3B927235-A535-4145-9ED2-E9F55BAE275CQ37835578-6E35480C-DF6D-4FED-B52F-49924818112AQ37895329-BCA3C8B4-B2DF-435D-8338-0F4611B92EBDQ37996828-65C1CF6A-4FA7-4007-BD47-BE4498BBC936Q38058413-0DC0D00C-B167-4970-8353-E828D89EF4E5Q38066413-C14541DE-DB59-4EF1-8A1B-468207CC9FF3Q38565607-7B91BA55-C2D4-4431-91E6-6F0A6B1B418DQ38629654-70F3E98C-46C2-4394-94AE-13B9C92307E7Q38847549-07932D21-AFE7-4B87-9DF2-80320DEC4CF0Q38954573-1112DBA0-4D88-4410-A3E3-5CCEAAC8E840Q39679757-8B826D49-81FF-4D4C-BA12-564962B83027Q41039563-A5A3FFBA-C3A3-409C-8CB3-FD9E9142A340Q43448049-36071843-EC7B-4976-A241-FA8C426F7823Q45362166-CB84F827-4B3B-43DB-B08F-66764A0E5AD1Q48028492-857D41C5-57F2-4285-9C87-FC508EEDD17BQ56898555-13964BF4-662E-4B60-945D-03772608C638
P2860
The aging immune system and its relationship to the development of chronic obstructive pulmonary disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The aging immune system and it ...... obstructive pulmonary disease.
@en
The aging immune system and it ...... obstructive pulmonary disease.
@nl
type
label
The aging immune system and it ...... obstructive pulmonary disease.
@en
The aging immune system and it ...... obstructive pulmonary disease.
@nl
prefLabel
The aging immune system and it ...... obstructive pulmonary disease.
@en
The aging immune system and it ...... obstructive pulmonary disease.
@nl
P2860
P1476
The aging immune system and it ...... obstructive pulmonary disease.
@en
P2093
Gulshan Sharma
Y Michael Shim
P2860
P304
P356
10.1513/PATS.200904-022RM
P577
2009-12-01T00:00:00Z